Mo1616: LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: POOLED INTERIM RESULTS FOR UP TO 3 YEARS FROM THE ASSURE STUDY

Eric Lawitz; Palak J. Trivedi; Kris V. Kowdley; Stuart C. Gordon; Christopher L. Bowlus; Maria C. Londoño; Gideon Hirschfield; Aliya Gulamhusein; Vicki Shah; Daria B. Crittenden; Shuqiong Zhuo; Carrie Heusner; Cynthia Levy

doi:10.1016/S0016-5085(25)05049-8

Back

Mo1616: LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: POOLED INTERIM RESULTS FOR UP TO 3 YEARS FROM THE ASSURE STUDY

Journal article

Peer reviewed

Mo1616: LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: POOLED INTERIM RESULTS FOR UP TO 3 YEARS FROM THE ASSURE STUDY

Eric Lawitz, Palak J. Trivedi, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, Maria C. Londoño, Gideon Hirschfield, Aliya Gulamhusein, Vicki Shah, Daria B. Crittenden, …

Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-1816-S-1817

2025-05

DOI: https://doi.org/10.1016/S0016-5085(25)05049-8

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: Mo1616: LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: POOLED INTERIM RESULTS FOR UP TO 3 YEARS FROM THE ASSURE STUDY
Creators: Eric Lawitz
Palak J. Trivedi
Kris V. Kowdley
Stuart C. Gordon
Christopher L. Bowlus
Maria C. Londoño
Gideon Hirschfield
Aliya Gulamhusein
Vicki Shah
Daria B. Crittenden
Shuqiong Zhuo
Carrie Heusner
Cynthia Levy
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-1816-S-1817
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991032730123802976